Featured Research

from universities, journals, and other organizations

Personalized Medicine Can Cut Breast Cancer Risk

Date:
February 19, 2008
Source:
University of Chicago Medical Center
Summary:
The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care. A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes. Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary step towards personalized medicine for women at risk.

Dr. Funmi Olopade counsels a patients in the Cancer Risk Clinic at the University of Chicago Medical Center.
Credit: Dan Dry for the University of Chicago Medical Center

The time has come for breast cancer risk assessment, counseling and genetic testing to move from cancer specialists to the realm of primary care, according to a presentation at the AAAS annual meeting, held this year in Boston.

Related Articles


"A growing body of evidence has documented the benefits of preventive measures for high-risk women including those with mutations in the BRCA1 and BRCA2 genes," said Funmi Olopade, MD, the Walter L Palmer Distinguished Service professor of medicine and director of the Cancer Risk Clinic at the University of Chicago Medical Center. "Referral for cancer-risk assessment and BRCA testing in the primary care setting is a necessary next step towards personalized medicine for women at risk for breast cancer."

Most high-risk women present in the primary care setting, she said. Primary care physicians should learn about the genetics of cancer risk, take a comprehensive personal and family history and advise patients who appear to be at increased risk about the plusses, minuses and limitations of genetic testing and risk-reduction strategies.

Physicians now have enough information to help patients understand the consequences of genetic testing, she added. Studies have found that genetic counseling and testing do not cause adverse psychological effects. There is convincing data on the risk reduction associated with prophylactic surgery--removal of the breasts and or ovaries to prevent cancer in those with known mutations. And preventive measures for those at risk now extend beyond pre-emptive surgery to intensive screening and chemoprevention.

"More than ten years after BRCA1 and BRCA2 were identified as major breast and ovarian cancer susceptibility genes," Olopade added, "primary care providers should embrace genetic risk assessment and BRCA mutation testing."

There is still a great deal that we don't know about these cancer-causing mutations, she added. The frequency and impact of BRCA1 and BRCA2 in various ethnic groups is still poorly understood, with conflicting results clouding the picture. As a consequence, genetic testing is underused by many ethnic groups.

Scientists are still finding new mutations of these genes. Some of these mutations increase disease risk and some may not. These genes may also interact with the environment or with other genes in ways that could modify their effects.

Even the methods of genetic testing can vary. Some tests look only for common mutations; others sequence the entire gene and look for tiny variations.

"There is still a great deal that we do not know about the role of these genes in inherited as well as sporadic breast cancer," said Olopade. "But we do know that mutation of these genes is common in families with hereditary breast cancer and among young women with breast cancer and that when we know a patient has a mutation there are several options to reduce the risk of breast cancer."

No other predictor is as powerful as an inherited mutation in the tumor-suppressor genes BRCA1 and BRCA2. "Our goal," Olopade said, "is to make this knowledge more and more available to patients, and that has to begin in the primary care setting. Only then can we hope to reap the benefits of individualized medicine."


Story Source:

The above story is based on materials provided by University of Chicago Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University of Chicago Medical Center. "Personalized Medicine Can Cut Breast Cancer Risk." ScienceDaily. ScienceDaily, 19 February 2008. <www.sciencedaily.com/releases/2008/02/080215103242.htm>.
University of Chicago Medical Center. (2008, February 19). Personalized Medicine Can Cut Breast Cancer Risk. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2008/02/080215103242.htm
University of Chicago Medical Center. "Personalized Medicine Can Cut Breast Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/2008/02/080215103242.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com
British Navy Ship Arrives in Sierra Leone With Ebola Aid

British Navy Ship Arrives in Sierra Leone With Ebola Aid

AFP (Oct. 30, 2014) The British ship RFA ARGUS arrived in Sierra Leone to deliver supplies and equipment to help the fight against Ebola. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins